Michael Altaweel

Summary

Affiliation: University of Wisconsin
Country: USA

Publications

  1. ncbi Macular hole: improved understanding of pathogenesis, staging, and management based on optical coherence tomography
    Michael Altaweel
    Department of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, WI, USA
    Semin Ophthalmol 18:58-66. 2003
  2. ncbi Treatment of central retinal vein occlusion with triamcinolone acetonide: an optical coherence tomography study
    Michael Ip
    Department of Ophthalmology and Visual Science, University of Wisconsin, Clinical Science Center, Madison, WI 53792, USA
    Semin Ophthalmol 18:67-73. 2003
  3. ncbi A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema
    Emmett T Cunningham
    Stanford University, USA
    Ophthalmology 112:1747-57. 2005
  4. ncbi Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals
    Anthony P Adamis
    Ophthalmology 113:23-8. 2006
  5. ncbi Characteristics of choroidal neovascularization in the complications of age-related macular degeneration prevention trial
    Maureen G Maguire
    Department of Ophthalmology, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104 3309, USA
    Ophthalmology 115:1468-73, 1473.e1-2. 2008

Collaborators

  • Michael Ip
  • Neil M Bessler
  • David J Wilson
  • Rajiv Anand
  • Dennis M Robertson
  • David J Browning
  • Susan B Bressler
  • N M Holekamp
  • Bruce R Garretson
  • Neil M Bressler
  • Anthony P Adamis
  • Emmett T Cunningham
  • Maureen G Maguire
  • David R Guyer
  • Mauro Goldbaum
  • Manju Patel
  • Cindy Armstrong
  • Lindy DuBois
  • Harold L Crider
  • Siobhan Sheehan
  • Steve Bloom
  • Judith Alexander
  • Judith E Belt
  • Thea Tantum
  • James Gilman
  • Lori Kaminski
  • Paul Sternberg
  • John Martin
  • Robin A Ty
  • Sharon M Millard
  • Miriam Kushner
  • Karina K Billiris
  • David Miller
  • Lori Lundy
  • Nancy Soueidan
  • Norma Jimenez
  • Annie Munana
  • T Michael Nork
  • Tammy Osentoski
  • Marsha Apushkin
  • Scott Pendergast
  • Wyatt Saxon
  • Patricia Bartholomew
  • Margo Blatz
  • Michelle M Kulak
  • Stephanie A Schura
  • Allen Ho
  • Cullen Mike Jones
  • Jack Cohen
  • Wendy Raunig
  • Michael Novak
  • Ellen Redenbo
  • Stefani Karakas
  • Everett Ai
  • Pat Manatrey
  • Scott E Bohnen
  • Tatyana Metelitsina
  • Michael Harker
  • Denise Krolnik
  • Deborah Elkins
  • Susan Anderson-Nelson
  • Sheri L Joyce
  • Dennis R Cain
  • Allen B Thach
  • Kevin Blinder
  • Mike McOwen
  • Claudette Geist
  • Patrick Rice
  • Judy Brower
  • Donna Coffey
  • Marilyn Katz
  • Jacquelyn M McDonald
  • Ann Ervin
  • Alan J Ruby
  • Celeste Figliulo
  • Steve Hobbs
  • William Nyberg
  • Molly Doherty
  • Stephanie Schmidt
  • Susan Sherouse
  • Monique N McRay
  • Michael Tolentino
  • H Richard McDonald
  • Barb Soderling
  • Cheryl Devine
  • Patricia Streasick
  • Jeffrey Heier
  • Zuzanna Rozenbajgier
  • Ellen Greenberg
  • Tarek S Hassan

Detail Information

Publications6

  1. ncbi Macular hole: improved understanding of pathogenesis, staging, and management based on optical coherence tomography
    Michael Altaweel
    Department of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, WI, USA
    Semin Ophthalmol 18:58-66. 2003
    ..OCT is useful in differentiating simulating lesions and in allowing better counseling of patients regarding their disorder. Finally, OCT findings are prognostic of surgical success and can assist in evaluating the results of surgery...
  2. ncbi Treatment of central retinal vein occlusion with triamcinolone acetonide: an optical coherence tomography study
    Michael Ip
    Department of Ophthalmology and Visual Science, University of Wisconsin, Clinical Science Center, Madison, WI 53792, USA
    Semin Ophthalmol 18:67-73. 2003
    ..Optical coherence tomography demonstrated significant anatomic improvement in the majority of patients with macular edema due to CRVO treated with intravitreal injection of triamcinolone acetonide...
  3. ncbi A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema
    Emmett T Cunningham
    Stanford University, USA
    Ophthalmology 112:1747-57. 2005
    ....
  4. ncbi Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals
    Anthony P Adamis
    Ophthalmology 113:23-8. 2006
    ..These findings suggest a direct effect of pegaptanib upon retinal neovascularization in patients with diabetes mellitus...
  5. ncbi Characteristics of choroidal neovascularization in the complications of age-related macular degeneration prevention trial
    Maureen G Maguire
    Department of Ophthalmology, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104 3309, USA
    Ophthalmology 115:1468-73, 1473.e1-2. 2008
    ..To describe the characteristics of incident choroidal neovascularization (CNV) in observed and treated eyes in the Complications of Age-related Macular Degeneration Prevention Trial (CAPT)...